MBRX
Moleculin Biotech Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.04
-0.01 ▼ -0.49%
🌙 3월 13일 7:06 PM ET (한국 3/14 08:06)
$2.02
-0.02 ▼ -0.98%
| Index | - | P/E | - | EPS (ttm) | -60.47 | Insider Own | - | Shs Outstand | 0.00B | Perf Week | -1.92% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 81.69% | Insider Trans | - | Shs Float | 0.00B | Perf Month | -51.2% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | -6.11 | Inst Own | 2.32% | Short Float | 6.31% | Perf Quarter | -57.76% |
| Income | -0.04B | P/S | - | EPS this Y | 76.99% | Inst Trans | 3.15% | Short Ratio | 0.68 | Perf Half Y | -78.3% |
| Sales | 0.00B | P/B | - | EPS next 5Y | 71.56% | ROA | -189.07% | Short Interest | 0.19M | Perf YTD | -38.37% |
| Book/sh | -13.6 | P/C | 1.5 | EPS past 3/5Y | 10.68% 26.36% | ROE | -503.8% | 52W High | -93.82% ($33.00) | Perf Year | -92.97% |
| Cash/sh | 1.36 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 13.97% ($1.79) | Perf 3Y | -99.44% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 79.31% | Gross Margin | - | Volatility(W/M) | 9.31% 9.06% | Perf 5Y | -99.88% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.28 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.39 | EPS Q/Q | 76.12% | Profit Margin | - | RSI (14) | 29.1 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.39 | Sales Q/Q | - | SMA20 | -22.09% ($2.62) | Beta | 1.74 | Target Price | $21 |
| Payout | - | Debt/Eq | - | Earnings | 2025/11/17 | SMA50 | -42.84% ($3.57) | Rel Volume | 0.53 | Prev Close | $2.05 |
| Employees | 17 | LT Debt/Eq | - | EPS/Sales Surpr. | -158.48% - | SMA200 | -79.4% ($9.9) | Avg Volume(3M) | 0.28M | Price | $2.04 |
| IPO | 2016/6/2 | Option/Short | No/Yes | Trades | 786 | Volume | 148,419 | Change | -0.49% |
뉴스 로딩 중...